Stabilization of cyclohexanone monooxygenase by computational and experimental library design.


Journal

Biotechnology and bioengineering
ISSN: 1097-0290
Titre abrégé: Biotechnol Bioeng
Pays: United States
ID NLM: 7502021

Informations de publication

Date de publication:
09 2019
Historique:
received: 21 03 2019
revised: 14 05 2019
accepted: 18 05 2019
pubmed: 28 5 2019
medline: 30 7 2020
entrez: 25 5 2019
Statut: ppublish

Résumé

Enzymes often by far exceed the activity, selectivity, and sustainability achieved with chemical catalysts. One of the main reasons for the lack of biocatalysis in the chemical industry is the poor stability exhibited by many enzymes when exposed to process conditions. This dilemma is exemplified in the usually very temperature-sensitive enzymes catalyzing the Baeyer-Villiger reaction, which display excellent stereo- and regioselectivity and offer a green alternative to the commonly used, explosive peracids. Here we describe a protein engineering approach applied to cyclohexanone monooxygenase from Rhodococcus sp. HI-31, a substrate-promiscuous enzyme that efficiently catalyzes the production of the nylon-6 precursor ε-caprolactone. We used a framework for rapid enzyme stabilization by computational libraries (FRESCO), which predicts protein-stabilizing mutations. From 128 screened point mutants, approximately half had a stabilizing effect, albeit mostly to a small degree. To overcome incompatibility effects observed upon combining the best hits, an easy shuffled library design strategy was devised. The most stable and highly active mutant displayed an increase in unfolding temperature of 13°C and an approximately 33x increase in half-life at 30°C. In contrast to the wild-type enzyme, this thermostable 8x mutant is an attractive biocatalyst for biotechnological applications.

Identifiants

pubmed: 31124128
doi: 10.1002/bit.27022
pmc: PMC6836875
doi:

Substances chimiques

Bacterial Proteins 0
Peptide Library 0
Oxygenases EC 1.13.-
cyclohexanone oxygenase EC 1.14.13.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2167-2177

Informations de copyright

© 2019 The Authors. Biotechnology and Bioengineering Immunity Inflammation Published by Wiley Periodicals, Inc.

Références

FEBS Open Bio. 2014 Feb 03;4:168-74
pubmed: 24649397
PLoS One. 2013 Oct 30;8(10):e78878
pubmed: 24205336
Methods Enzymol. 2018;608:151-187
pubmed: 30173762
Curr Opin Struct Biol. 2019 Dec;59:29-37
pubmed: 30831329
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W382-8
pubmed: 15980494
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13157-62
pubmed: 15328411
J Biotechnol. 2015 Nov 20;214:199-211
pubmed: 26410456
BMC Biotechnol. 2008 Dec 04;8:91
pubmed: 19055817
Chem Rev. 2011 Jul 13;111(7):4165-222
pubmed: 21542563
Biochemistry. 2001 Sep 18;40(37):11156-67
pubmed: 11551214
Protein Eng Des Sel. 2014 Feb;27(2):49-58
pubmed: 24402331
Angew Chem Int Ed Engl. 2016 Dec 19;55(51):15852-15855
pubmed: 27873437
PLoS One. 2009;4(5):e5553
pubmed: 19436741
Appl Microbiol Biotechnol. 2016 Aug;100(15):6585-6599
pubmed: 27328941
ACS Chem Biol. 2014 Dec 19;9(12):2843-51
pubmed: 25265531
Appl Microbiol Biotechnol. 2017 Oct;101(20):7557-7565
pubmed: 28916997
Biotechnol Bioeng. 2019 Sep;116(9):2167-2177
pubmed: 31124128
J Am Chem Soc. 2017 Jan 18;139(2):627-630
pubmed: 28010060
FEBS J. 2009 May;276(10):2833-40
pubmed: 19459938
Appl Microbiol Biotechnol. 2014 May;98(9):4009-20
pubmed: 24247989
Biotechnol Prog. 2002 Sep-Oct;18(5):1039-46
pubmed: 12363355
ACS Catal. 2018 Dec 7;8(12):11648-11656
pubmed: 30687578
Biotechnol Adv. 2018 Jan - Feb;36(1):247-263
pubmed: 29174001
Chembiochem. 2010 Dec 10;11(18):2589-96
pubmed: 21080396
Protein Eng Des Sel. 2017 Mar 1;30(3):173-187
pubmed: 27999093
J Am Chem Soc. 2012 May 9;134(18):7788-95
pubmed: 22506764
J Am Chem Soc. 2009 Oct 28;131(42):15424-32
pubmed: 19807086
Chembiochem. 2014 Jul 21;15(11):1660-72
pubmed: 24976371
Biotechnol Bioeng. 2015 Jul;112(7):1354-64
pubmed: 25675885
PLoS One. 2015 Jul 10;10(7):e0132689
pubmed: 26161776
J Biotechnol. 2010 Mar;146(1-2):9-24
pubmed: 20132846
Bioinformatics. 2014 Oct 15;30(20):2981-2
pubmed: 24996895
Biotechnol Biofuels. 2018 Mar 1;11:56
pubmed: 29507608
J Mol Biol. 2002 Jul 5;320(2):369-87
pubmed: 12079393
Methods Mol Biol. 2018;1685:69-85
pubmed: 29086304
J Am Chem Soc. 2012 Feb 8;134(5):2732-41
pubmed: 22239272
Protein Sci. 2018 Jan;27(1):112-128
pubmed: 28836357
J Am Chem Soc. 2018 Aug 22;140(33):10464-10472
pubmed: 30044629
J Am Chem Soc. 2009 Jul 1;131(25):8848-54
pubmed: 19385644
ACS Synth Biol. 2013 Aug 16;2(8):473-7
pubmed: 23654272
Appl Microbiol Biotechnol. 2005 Jan;66(4):393-400
pubmed: 15599520
Chembiochem. 2009 Nov 2;10(16):2595-8
pubmed: 19795432
Proteins. 2011 Mar;79(3):830-8
pubmed: 21287615

Auteurs

Maximilian J L J Fürst (MJLJ)

Molecular Enzymology Group, University of Groningen, Groningen, The Netherlands.

Marjon Boonstra (M)

Molecular Enzymology Group, University of Groningen, Groningen, The Netherlands.

Selle Bandstra (S)

Molecular Enzymology Group, University of Groningen, Groningen, The Netherlands.

Marco W Fraaije (MW)

Molecular Enzymology Group, University of Groningen, Groningen, The Netherlands.

Articles similaires

Photosynthesis Ribulose-Bisphosphate Carboxylase Carbon Dioxide Molecular Dynamics Simulation Cyanobacteria
T-Lymphocytes, Regulatory Lung Neoplasms Proto-Oncogene Proteins p21(ras) Animals Humans

Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis.

Spencer D Shelton, Sara House, Luiza Martins Nascentes Melo et al.
1.00
DNA, Mitochondrial Humans Melanoma Mutation Neoplasm Metastasis

Prevalence and implications of fragile X premutation screening in Thailand.

Areerat Hnoonual, Sunita Kaewfai, Chanin Limwongse et al.
1.00
Humans Fragile X Mental Retardation Protein Thailand Male Female

Classifications MeSH